Envista Obtains FDA Clearance for Assisted Intelligence Mandibular Nerve Tracing

BREA, Calif., March 28, 2022 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) — Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Intelligence (AI) mandibular nerve tracing feature in its image acquisition and diagnostic…